HANALL Biopharma is developing innovative therapies to address unmet medical needs. They have a novel, topical, anti-TNF alpha protein drug for the treatment of inflammatory eye diseases, and a novel, anti-FcRn antibody for the treatment of autoimmune diseases.
| Contact Details | Daewoong Building 3F, 12 Bongeunsa-ro 114-gil, Gangnam-gu, SeoulCustomer center: +82 1644-5515Emails: sales.info@hanall.co.kr, ir@hanall.com |
|---|
